Učitavanje...
Intermediate hepatocellular carcinoma: the role of transarterial therapy
According to Barcelona Clinic Liver Cancer, the recommended first-line treatment for patients with intermediate stage of hepatocellular carcinoma (HCC) is transarterial chemoembolization. Patients with intermediate stage of HCC represent 20% with a 2-year survival of approximately 50%. Nowadays, tra...
Spremljeno u:
| Izdano u: | Hepat Oncol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Future Medicine Ltd
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4792112/ https://ncbi.nlm.nih.gov/pubmed/26998220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.15.32 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|